Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers


-0.016 (-2.44%)
Feb 24 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 744,237
Bid Price 0.639
Ask Price 0.68
News -
Day High 0.6559


52 Week Range


Day Low 0.6105
Company Name Stock Ticker Symbol Market Type
HOOKIPA Pharma Inc HOOK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.016 -2.44% 0.64 00:00:08
Open Price Low Price High Price Close Price Prev Close
0.64 0.6105 0.6559 0.6401 0.656
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,509 744,237 $ 0.6398379 $ 476,191 - 0.41 - 2.05
Last Trade Time Type Quantity Stock Price Currency
19:04:18 1 $ 0.6409 USD

HOOKIPA Pharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
53.73M 83.95M - 14.25M -64.92M -0.77 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

HOOKIPA Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No HOOK Message Board. Create One! See More Posts on HOOK Message Board See More Message Board Posts

Historical HOOK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.66280.6949990.61050.6605799487,667-0.0228-3.44%
1 Month0.70810.730.57890.6510545544,443-0.0681-9.62%
3 Months0.571.130.540.81709992,669,1060.0712.28%
6 Months0.6811.130.410.7719791,421,554-0.041-6.02%
1 Year0.892.050.410.92466611,146,807-0.25-28.09%
3 Years11.8520.000.412.131,182,487-11.21-94.60%
5 Years14.0020.000.412.47761,978-13.36-95.43%

HOOKIPA Pharma Description

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Your Recent History

Delayed Upgrade Clock